CAS 2222138-40-9

Sotuletinib dihydrochloride

CAS: 2222138-40-9

Sotuletinib (BLZ945) dihydrochloride is an orally administered, blood-brain barrier-permeable inhibitor specifically targeting CSF1-R with an IC50 of 1 nM.

Formel: C₂₀H₂₄Cl₂N₄O₃S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 471.4

Ref: TM-T78603